UniProtKB/Swiss-Prot P02461: Variant p.Pro668Thr

Collagen alpha-1(III) chain
Gene: COL3A1
Feedback?

Variant information Variant position:

668 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant:

LB/B The variants are classified into three categories: LP/P, LB/B and US.

LP/P: likely pathogenic or pathogenic.
LB/B: likely benign or benign.
US: uncertain significance

Residue change:

From Proline (P) to Threonine (T) at position 668 (P668T, p.Pro668Thr). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties:

Change from medium size and hydrophobic (P) to medium size and polar (T) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score:

-1 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:

Lowest score: -4 (low probability of substitution).
Highest score: 11 (high probability of substitution).

More information can be found on the following page
Other resources:

Links to websites of interest for the variant.

Variant rs1801183 [ dbSNP | Ensembl ]

Sequence information Variant position:

668 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length:

1466 The length of the canonical sequence.
Location on the sequence:

GPPGENGKPGEPGPKGDAGA P GAPGGKGDAGAPGERGPPGL The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation:

The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         GPPGENGKPGEPGPKGDAGAPGAPGGKGDAGAPGERGPPGL

Mouse                         GPPGENGKPGEPGPKGEVGAPGAPGGKGDSGAPGERGPPGT

Rat                           GPPGENGKPGEPGPKGEAGAPGVPGGKGDSGAPGERGPPGT

Bovine                        GPPGENGKPGEPGPKGEAGAPGIPGGKGDSGAPGERGPPGA

Sequence annotation in neighborhood:

The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:

Type: the type of sequence feature.
Positions: endpoints of the sequence feature.
Description: contains additional information about the feature.

Type	Positions	Description
Chain	154 – 1221	Collagen alpha-1(III) chain
Region	95 – 1194	Disordered
Region	168 – 1196	Triple-helical region
Modified residue	650 – 650	4-hydroxyproline
Modified residue	656 – 656	4-hydroxyproline
Modified residue	659 – 659	4-hydroxyproline
Modified residue	661 – 661	4-hydroxyproline
Modified residue	668 – 668	4-hydroxyproline
Modified residue	671 – 671	4-hydroxyproline
Modified residue	680 – 680	4-hydroxyproline
Modified residue	686 – 686	4-hydroxyproline

Literature citations
Sequencing of cDNA from 50 unrelated patients reveals that mutations in the triple-helical domain of type III procollagen are an infrequent cause of aortic aneurysms.
Tromp G.; Wu Y.; Prockop D.J.; Madhatheri S.L.; Kleinert C.; Earley J.J.; Zhuang J.; Noerrgaard O.; Darling R.C.; Abbott W.M.; Cole C.W.; Jaakkola P.; Ryynaenen M.; Pearce W.H.; Yao J.S.T.; Majamaa K.; Smullens S.N.; Gatalica Z.; Ferrell R.E.; Jimenez S.A.; Jackson C.E.; Michels V.V.; Kaye M.; Kuivaniemi H.;
J. Clin. Invest. 91:2539-2545(1993)
Cited for: VARIANT EDSVASC ARG-303; VARIANT THR-668;

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.